19171933_1|19171933|12934|#section_info|0:0|Depletion of beta-arrestin-2 not only leads to increases (up to  ~150%) in the induction of cleaved caspase-3 levels by treatment with  hydrogen peroxide or etoposide, but also eliminates AngII-mediated decreases|#main_body|GO:0043065|positive regulation of apoptotic process|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
0.74	19171933_78|19171933|18039|RESULTS|0:0|As shown in  Fig. 1, H and  I, stimulation of the cells with SII leads to significant  decreases (35-45%) in the levels of cleaved caspase-3 upon hydrogen peroxide  or etoposide treatment.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_86|19171933|18949|RESULTS|0:0|C and D, contents of cleaved  caspase-3 in the immunoblots were quantified and expressed as percent of the  level obtained in H2O2-(C) or etoposide-  (D) treated cells in the absence of stimulation with AngII.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19171933_2|19171933|12934|#section_info|0:0|On the other hand, knocking-down beta-arrestin-1  leads to decreases in apoptotic reagent-induced caspase-3 cleavage even in the  absence of stimulation with AngII, which is similar in extent to the  protection observed in AngII-treated control cells. |#main_body|GO:0043066|negative regulation of apoptotic process|#go_definition|IMP|GOA|Arrb1(25387)|#gene_synonym
0.65	19171933_86|19171933|18949|RESULTS|0:0|C and D, contents of cleaved  caspase-3 in the immunoblots were quantified and expressed as percent of the  level obtained in H2O2-(C) or etoposide-  (D) treated cells in the absence of stimulation with AngII.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_78|19171933|18039|RESULTS|0:0|As shown in  Fig. 1, H and  I, stimulation of the cells with SII leads to significant  decreases (35-45%) in the levels of cleaved caspase-3 upon hydrogen peroxide  or etoposide treatment.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_103|19171933|20791|RESULTS|0:0|Moreover, our recent high  throughput proteomics screening using the stable isotope labeling amino acid  in cell culture method have revealed that the level of p90RSK phosphorylation  is increased by SII stimulation in HEK-293 cells expressing the  AT1A  receptor.3  Accordingly, we next tested whether phosphorylation of p90RSK occurs upon  stimulation with AngII and whether this is mediated by beta-arrestin-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_198|19171933|41648|DISCUSSION|0:0|A-E, cells were transfected with the indicated siRNAs and  serum starved for ~6 h. During starvation, inhibitors were pre-treated  before stimulation: 1 mum Ro31-8425, 2.5 mum  GF109203X (GFX), and 5 mum U0126 for 30 min; 100  mum SL0101 for 2 h. After stimulation with 100 nm  AngII at 37  C for the indicated periods, whole cell extracts were  prepared to visualize expression beta-arrestins (A) and  phosphorylation of p90RSK at Thr359/Ser363 (B)  and BAD at Ser75 (D) by immunoblotting (IB).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_12|19171933|1260|abstract|0:0|For example, it has been shown that stimulation of a number of 7TMRs including  the N-formyl peptide receptor induces apoptosis in beta-arrestin  1/2 double knock-out mouse embryonic fibroblasts, and that reintroduction of  either beta-arrestin-1 or -2 completely prevents this apoptosis  (5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_28|19171933|3755|abstract|0:0|Stimulation of the  AT1 receptor also has been shown to activate AKT in several cell  types including vascular smooth muscle cells (VSMCs)  (28,  29) although it has not been  determined whether beta-arrestins are involved in this signaling.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_76|19171933|18039|RESULTS|0:0|To establish whether the beta-arrestin-2-dependent  AT1R-mediated inhibition of apoptotic processes can be accomplished  in the absence of G protein activation, we stimulated VSMCs with an AngII  analog, [Sar1,Ile4,Ile8]AngII (SII).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_141|19171933|29883|RESULTS|0:0|In contrast, the protein kinase C (PKC) inhibitor  Ro31-8425 or GF109203X, which has been shown in HEK-293 cells to block G  protein-dependent ERK activation by AngII  (21,  22), inhibits the early  component of p90RSK activation (Fig. 4C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_144|19171933|31858|RESULTS|0:0|Despite this evidence that beta-arrestin-2-mediated ERK activation  accounts for only the later (>5 min) occurring phosphorylation of p90RSK,  the data in Fig. 4, D and  E, suggest that, as in the VSMCs, almost all of the  downstream phosphorylation of BAD by RSK is mediated by the pool of p90RSK,  which is activated through beta-arrestin-dependent ERK.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_191|19171933|40327|DISCUSSION|0:0|In the case of AKT  for example, it has been reported that deficiency of beta-arrestins 1 and 2  leads to loss of AKT activation and anti-apoptotic effects following  insulin-like growth factor 1 stimulation in mouse embryonic fibroblasts  (6).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19171933_3|19171933|15232|#section_info|0:0|However, unlike control  siRNA-transfected cells, pre-stimulation with AngII fails to reverse the  hydrogen peroxide-induced mitochondrial fragmentation in beta-arrestin-2  siRNA-transfected cells |#main_body|GO:0090200|positive regulation of release of cytochrome c from mitochondria|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
##EndOfRet##
19171933_4|19171933|17079|#section_info|0:0|On the contrary, we did not observe decreases in DNA  fragmentation after prestimulation with AngII in beta-arrestin-2  siRNA-transfected cells|#main_body|GO:0006309|apoptotic DNA fragmentation|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
##EndOfRet##
19171933_5|19171933|17079|#section_info|0:0|In the case of beta-arrestin-1 knock-down, effects on DNA  fragmentation also mirror the effects observed with caspase-3 cleavage |#main_body|GO:0006309|apoptotic DNA fragmentation|#go_definition|IMP|GOA|Arrb1(25387)|#gene_synonym
##EndOfRet##
19171933_6|19171933|20791|#section_info|0:0|Here we demonstrate that in VSMCs stimulated with AngII, ERK1/2 are activated,  and this is significantly reduced by siRNA-mediated knock-down of  beta-arrestin-2 (Fig. 2,  A-C).|#main_body|GO:0070374|positive regulation of ERK1 and ERK2 cascade|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
0.71	19171933_28|19171933|3755|abstract|0:0|Stimulation of the  AT1 receptor also has been shown to activate AKT in several cell  types including vascular smooth muscle cells (VSMCs)  (28,  29) although it has not been  determined whether beta-arrestins are involved in this signaling.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19171933_103|19171933|20791|RESULTS|0:0|Moreover, our recent high  throughput proteomics screening using the stable isotope labeling amino acid  in cell culture method have revealed that the level of p90RSK phosphorylation  is increased by SII stimulation in HEK-293 cells expressing the  AT1A  receptor.3  Accordingly, we next tested whether phosphorylation of p90RSK occurs upon  stimulation with AngII and whether this is mediated by beta-arrestin-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19171933_141|19171933|29883|RESULTS|0:0|In contrast, the protein kinase C (PKC) inhibitor  Ro31-8425 or GF109203X, which has been shown in HEK-293 cells to block G  protein-dependent ERK activation by AngII  (21,  22), inhibits the early  component of p90RSK activation (Fig. 4C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19171933_238|19171933|48008|DISCUSSION|0:0|Furthermore, ERK and AKT  activation in SMCs of injured arteries is reduced in beta-arrestin-2  knock-out mice compared with wild-type animals  (48).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_122|19171933|28193|RESULTS|0:0|A-G, indicated siRNA-transfected VSMCs were serum-starved  for ~24 h and then stimulated with 100 nm AngII at 37  C  for the indicated periods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_131|19171933|28193|RESULTS|0:0|J and K,  siRNA-transfected VSMCs were serum-starved and then stimulated with 100  nm AngII for the indicated periods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_138|19171933|29883|RESULTS|0:0|However, such experiments are  only relevant to the situation in VSMCs if the signaling pathway we have  identified in the VSMCs also operates in the HEK-293 cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_144|19171933|31858|RESULTS|0:0|Despite this evidence that beta-arrestin-2-mediated ERK activation  accounts for only the later (>5 min) occurring phosphorylation of p90RSK,  the data in Fig. 4, D and  E, suggest that, as in the VSMCs, almost all of the  downstream phosphorylation of BAD by RSK is mediated by the pool of p90RSK,  which is activated through beta-arrestin-dependent ERK.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_12|19171933|1260|abstract|0:0|For example, it has been shown that stimulation of a number of 7TMRs including  the N-formyl peptide receptor induces apoptosis in beta-arrestin  1/2 double knock-out mouse embryonic fibroblasts, and that reintroduction of  either beta-arrestin-1 or -2 completely prevents this apoptosis  (5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_102|19171933|20791|RESULTS|0:0|Furthermore, RSK is  activated by phosphorylation in the cytoplasm  (40,  41) where ERK activated by  beta-arrestin-dependent mechanisms is confined  (22,  26).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_150|19171933|32755|RESULTS|0:0|4 confirm that the  AT1R-beta-arrestin-2-ERK-p90RSK-BAD pathway delineated in rat  VSMCs (Fig. 2) is also  operative in HEK-293 cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_3|19171933|96|abstract|0:0|Here we demonstrate that  beta-arrestin-2 mediates anti-apoptotic cytoprotective signaling stimulated  by a typical 7-transmembrane receptor the angiotensin ATII 1A receptor,  expressed endogenously in rat vascular smooth muscle cells or by transfection  in HEK-293 cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_163|19171933|36633|DISCUSSION|0:0|In particular, ERK  activated via the beta-arrestin-2-dependent pathway is confined to the  cytoplasm, whereas ERK activated via G proteins translocates into the nucleus  (22,  26).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_5|19171933|96|abstract|0:0|Anti-apoptotic effects as well as  pathway activities can be stimulated by an angiotensin analog (SII), which has  been previously shown to activate beta-arrestin but not G protein-dependent  signaling, and are abrogated by beta-arrestin-2 small interfering RNA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_76|19171933|18039|RESULTS|0:0|To establish whether the beta-arrestin-2-dependent  AT1R-mediated inhibition of apoptotic processes can be accomplished  in the absence of G protein activation, we stimulated VSMCs with an AngII  analog, [Sar1,Ile4,Ile8]AngII (SII).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_161|19171933|36633|DISCUSSION|0:0|In the case of AT1AR-mediated ERK activation, it has been  demonstrated that upon activation of the receptor, beta-arrestin-2 scaffolds  the components of the ERK cascade, Raf-1, MEK1, and ERK1/2, into the receptor  complex, leading to activation of ERK1/2  (2,  43).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19171933_7|19171933|20791|#section_info|0:0|In control siRNA-transfected cells, p90RSK phosphorylation  also reaches a maximal level at 5 min after stimulation although it lags  slightly behind ERK activation Silencing beta-arrestin-2 expression  leads to rapid and transient p90RSK phosphorylation, also similar to ERK|#main_body|GO:0001934|positive regulation of protein phosphorylation|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
0.69	19171933_144|19171933|31858|RESULTS|0:0|Despite this evidence that beta-arrestin-2-mediated ERK activation  accounts for only the later (>5 min) occurring phosphorylation of p90RSK,  the data in Fig. 4, D and  E, suggest that, as in the VSMCs, almost all of the  downstream phosphorylation of BAD by RSK is mediated by the pool of p90RSK,  which is activated through beta-arrestin-dependent ERK.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19171933_24|19171933|3755|abstract|0:0|In the case of  AT1AR-mediated ERK activation in receptor-transfected human  embryonic kidney (HEK)-293 cells, for example, the G protein-dependent  activation is rapid, quite transient (peak at 2-5 min), and leads to nuclear  translocation of the activated ERK.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19171933_142|19171933|29883|RESULTS|0:0|Confirming that virtually all of the AngII-induced  phosphorylation of p90RSK at Thr359 and Ser363 is  mediated by ERK, the MEK inhibitor U0126 completely abolishes the p90RSK  phosphorylation response (Fig. 4C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19171933_143|19171933|29883|RESULTS|0:0|These patterns of sensitivities to PKC blockade and  beta-arrestin-2 siRNA directly parallel our previous findings for  AngII-stimulated phosphorylation of ERK in these cells  (22).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19171933_103|19171933|20791|RESULTS|0:0|Moreover, our recent high  throughput proteomics screening using the stable isotope labeling amino acid  in cell culture method have revealed that the level of p90RSK phosphorylation  is increased by SII stimulation in HEK-293 cells expressing the  AT1A  receptor.3  Accordingly, we next tested whether phosphorylation of p90RSK occurs upon  stimulation with AngII and whether this is mediated by beta-arrestin-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19171933_141|19171933|29883|RESULTS|0:0|In contrast, the protein kinase C (PKC) inhibitor  Ro31-8425 or GF109203X, which has been shown in HEK-293 cells to block G  protein-dependent ERK activation by AngII  (21,  22), inhibits the early  component of p90RSK activation (Fig. 4C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19171933_198|19171933|41648|DISCUSSION|0:0|A-E, cells were transfected with the indicated siRNAs and  serum starved for ~6 h. During starvation, inhibitors were pre-treated  before stimulation: 1 mum Ro31-8425, 2.5 mum  GF109203X (GFX), and 5 mum U0126 for 30 min; 100  mum SL0101 for 2 h. After stimulation with 100 nm  AngII at 37  C for the indicated periods, whole cell extracts were  prepared to visualize expression beta-arrestins (A) and  phosphorylation of p90RSK at Thr359/Ser363 (B)  and BAD at Ser75 (D) by immunoblotting (IB).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19171933_104|19171933|20791|RESULTS|0:0|As  shown in Fig. 2, D and  E, the kinetic pattern of AngII-stimulated p90RSK  phosphorylation, particularly at ERK sites Thr359/Ser363  (40,  41), is similar to that for  ERK activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19171933_125|19171933|28193|RESULTS|0:0|Values were expressed as percent of the maximal phosphorylation  of ERK1/2 obtained in control (CTL) siRNA-transfected cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19171933_129|19171933|28193|RESULTS|0:0|The level of SII-induced p90RSK and BAD phosphorylation were  determined as described above and expressed folds over basal phosphorylation  in non-stimulated (NS) cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19171933_134|19171933|29883|RESULTS|0:0|The AT1AR-stimulated ERK-RSK-BAD Phosphorylation Cascade in  HEK-293 Cells Is Also Mediated by  beta-Arrestin-2:Phosphorylation of BAD is thought to control  its apoptotic activity by regulating its functionally antagonistic binding to  anti-apoptotic proteins such as Bcl-xL (dephosphorylated form)  (11,  20) or the scaffold protein  14-3-3 (phosphorylated form)  (19).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_161|19171933|36633|DISCUSSION|0:0|In the case of AT1AR-mediated ERK activation, it has been  demonstrated that upon activation of the receptor, beta-arrestin-2 scaffolds  the components of the ERK cascade, Raf-1, MEK1, and ERK1/2, into the receptor  complex, leading to activation of ERK1/2  (2,  43).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_206|19171933|43088|DISCUSSION|0:0|We show that p90RSK is a kinase that transfers the beta-arrestin-mediated  ERK activation signal to anti-apoptotic effects in response to AT1  receptor activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_166|19171933|36633|DISCUSSION|0:0|However, very little is  known about how phosphorylation of cytoplasmic ERK substrates, downstream of  beta-arrestin signaling, regulates cellular responses.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_197|19171933|41648|DISCUSSION|0:0|beta-Arrestin-2 also mediates the ERK-RSK-BAD phosphorylation cascade  upon stimulation of the AT1A receptor stably expressed in HEK-293  cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_210|19171933|43088|DISCUSSION|0:0|Nonetheless, our data  show that inhibition of either ERK or RSK, but not PI3K activities completely  abolishes phosphorylation of BAD at this site following activation of the  AT1 receptor (Figs. 3B and  4E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_175|19171933|38423|DISCUSSION|0:0|B, after stimulation with AngII for 5 min,  phosphorylation of AKT at Ser473 and BAD at Ser113 were  visualized by immunoblotting (IB).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_199|19171933|41648|DISCUSSION|0:0|Levels of p90RSK (C) and BAD (D) phosphorylation in each  sample were determined as described for  Fig. 2 and expressed as percent  of the maximal phosphorylation in control (CTL) siRNA-transfected  cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_121|19171933|28193|RESULTS|0:0|Effects of silencing beta-arrestin-2 expression on ERK-RSK-BAD  phosphorylation as well as AKT activation in response to AngII in rat  VSMCs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_123|19171933|28193|RESULTS|0:0|After stimulation, expression of beta-arrestins  (A) and phosphorylation of ERK1/2 (B), p90RSK at  Thr359/Ser363 (D), and BAD at Ser113  (F) were visualized by immunoblotting (IB).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19171933_8|19171933|23332|#section_info|0:0|In these cells, beta-arrestin-2  RNA interference interestingly leads to almost complete attenuation in  AT1R-mediated BAD phosphorylation  |#main_body|GO:0001934|positive regulation of protein phosphorylation|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
0.65	19171933_145|19171933|31858|RESULTS|0:0|After  beta-arrestin-2 siRNA transfection, there is almost complete loss of the  AngII-stimulated BAD phosphorylation at Ser75, the homologous site  of Ser113 in human BAD (Fig. 4,  D and E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_134|19171933|29883|RESULTS|0:0|The AT1AR-stimulated ERK-RSK-BAD Phosphorylation Cascade in  HEK-293 Cells Is Also Mediated by  beta-Arrestin-2:Phosphorylation of BAD is thought to control  its apoptotic activity by regulating its functionally antagonistic binding to  anti-apoptotic proteins such as Bcl-xL (dephosphorylated form)  (11,  20) or the scaffold protein  14-3-3 (phosphorylated form)  (19).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_103|19171933|20791|RESULTS|0:0|Moreover, our recent high  throughput proteomics screening using the stable isotope labeling amino acid  in cell culture method have revealed that the level of p90RSK phosphorylation  is increased by SII stimulation in HEK-293 cells expressing the  AT1A  receptor.3  Accordingly, we next tested whether phosphorylation of p90RSK occurs upon  stimulation with AngII and whether this is mediated by beta-arrestin-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19171933_9|19171933|24568|#section_info|0:0|Accordingly, we tested the  ability of AngII to promote phosphorylation of the stimulatory site,  Ser473, of AKT in the VSMCs. As shown in  Fig. 2, J and  K, time-dependent phosphorylation was observed, which was  inhibited by beta-arrestin-2 siRNAs at times later than 2 min of  stimulation, indicating that this process is mediated in part by|#main_body|GO:0051897|positive regulation of protein kinase B signaling cascade|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
0.79	19171933_144|19171933|31858|RESULTS|0:0|Despite this evidence that beta-arrestin-2-mediated ERK activation  accounts for only the later (>5 min) occurring phosphorylation of p90RSK,  the data in Fig. 4, D and  E, suggest that, as in the VSMCs, almost all of the  downstream phosphorylation of BAD by RSK is mediated by the pool of p90RSK,  which is activated through beta-arrestin-dependent ERK.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.75	19171933_103|19171933|20791|RESULTS|0:0|Moreover, our recent high  throughput proteomics screening using the stable isotope labeling amino acid  in cell culture method have revealed that the level of p90RSK phosphorylation  is increased by SII stimulation in HEK-293 cells expressing the  AT1A  receptor.3  Accordingly, we next tested whether phosphorylation of p90RSK occurs upon  stimulation with AngII and whether this is mediated by beta-arrestin-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.74	19171933_28|19171933|3755|abstract|0:0|Stimulation of the  AT1 receptor also has been shown to activate AKT in several cell  types including vascular smooth muscle cells (VSMCs)  (28,  29) although it has not been  determined whether beta-arrestins are involved in this signaling.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.72	19171933_141|19171933|29883|RESULTS|0:0|In contrast, the protein kinase C (PKC) inhibitor  Ro31-8425 or GF109203X, which has been shown in HEK-293 cells to block G  protein-dependent ERK activation by AngII  (21,  22), inhibits the early  component of p90RSK activation (Fig. 4C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19171933_108|19171933|24202|RESULTS|0:0|As  shown in Fig. 2, H and  I, SII stimulates both p90RSK and phosphorylation of BAD  at the RSK site, thus confirming the G protein independence of these  responses.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.71	19171933_211|19171933|43088|DISCUSSION|0:0|Such data clearly  demonstrate that BAD phosphorylation at Ser113 in response to  AT1 receptor activation is mediated through the ERK-RSK pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19171933_131|19171933|28193|RESULTS|0:0|J and K,  siRNA-transfected VSMCs were serum-starved and then stimulated with 100  nm AngII for the indicated periods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19171933_193|19171933|40327|DISCUSSION|0:0|Our present data show that stimulation of the  AT1 receptor leads to AKT activation in a  beta-arrestin-2-dependent manner (Fig. 2,  J and K).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19171933_198|19171933|41648|DISCUSSION|0:0|A-E, cells were transfected with the indicated siRNAs and  serum starved for ~6 h. During starvation, inhibitors were pre-treated  before stimulation: 1 mum Ro31-8425, 2.5 mum  GF109203X (GFX), and 5 mum U0126 for 30 min; 100  mum SL0101 for 2 h. After stimulation with 100 nm  AngII at 37  C for the indicated periods, whole cell extracts were  prepared to visualize expression beta-arrestins (A) and  phosphorylation of p90RSK at Thr359/Ser363 (B)  and BAD at Ser75 (D) by immunoblotting (IB).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19171933_104|19171933|20791|RESULTS|0:0|As  shown in Fig. 2, D and  E, the kinetic pattern of AngII-stimulated p90RSK  phosphorylation, particularly at ERK sites Thr359/Ser363  (40,  41), is similar to that for  ERK activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19171933_116|19171933|26491|RESULTS|0:0|To directly test whether RSK- and AKT-mediated phosphorylation of BAD are  required for the anti-apoptotic actions of AngII, we studied the nature of  overexpressed wild-type and phosphorylation-deficient mutants of BAD in VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19171933_142|19171933|29883|RESULTS|0:0|Confirming that virtually all of the AngII-induced  phosphorylation of p90RSK at Thr359 and Ser363 is  mediated by ERK, the MEK inhibitor U0126 completely abolishes the p90RSK  phosphorylation response (Fig. 4C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19171933_175|19171933|38423|DISCUSSION|0:0|B, after stimulation with AngII for 5 min,  phosphorylation of AKT at Ser473 and BAD at Ser113 were  visualized by immunoblotting (IB).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19171933_29|19171933|5441|abstract|0:0|Accordingly, the studies reported here were undertaken to examine the role  of beta-arrestin in 7TMR-regulated apoptosis and to determine the downstream  pathways mediating this regulation in a physiologically relevant  non-transfected cellular receptor system.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19171933_102|19171933|20791|RESULTS|0:0|Furthermore, RSK is  activated by phosphorylation in the cytoplasm  (40,  41) where ERK activated by  beta-arrestin-dependent mechanisms is confined  (22,  26).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19171933_134|19171933|29883|RESULTS|0:0|The AT1AR-stimulated ERK-RSK-BAD Phosphorylation Cascade in  HEK-293 Cells Is Also Mediated by  beta-Arrestin-2:Phosphorylation of BAD is thought to control  its apoptotic activity by regulating its functionally antagonistic binding to  anti-apoptotic proteins such as Bcl-xL (dephosphorylated form)  (11,  20) or the scaffold protein  14-3-3 (phosphorylated form)  (19).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19171933_168|19171933|36633|DISCUSSION|0:0|The present study  reveals anti-apoptosis mediated by BAD phosphorylation as another downstream  response of beta-arrestin-mediated ERK signaling stimulated by a 7TMR.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19171933_170|19171933|38423|DISCUSSION|0:0|Kinase activities of both RSK and AKT as well as BAD phosphorylation are  required for AngII-promoted cellular protection in rat VSMCs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19171933_5|19171933|96|abstract|0:0|Anti-apoptotic effects as well as  pathway activities can be stimulated by an angiotensin analog (SII), which has  been previously shown to activate beta-arrestin but not G protein-dependent  signaling, and are abrogated by beta-arrestin-2 small interfering RNA.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19171933_111|19171933|25257|RESULTS|0:0|To test this hypothesis, we first examined the effects of the RSK  inhibitor SL0101 and the PI3K inhibitor LY294002, which is known to block AKT  activation, on AngII-induced anti-apoptosis in VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19171933_113|19171933|25257|RESULTS|0:0|Fig. 3B shows that  LY294002 blocks AngII-induced activation of AKT as assessed by phosphorylation  of AKT Ser473, and SL0101 blocks phosphorylation of BAD at the RSK  site, BAD Ser113.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19171933_159|19171933|35315|DISCUSSION|0:0|The results reported  here establish a downstream molecular mechanism by which beta-arrestin-2  mediates anti-apoptosis in response to activation of the physiologically  important AT1 receptor in a non-transfected natural cell, VSMC.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.65	19171933_167|19171933|36633|DISCUSSION|0:0|The only known  example is the very recent finding that beta-arrestin-2-mediated ERK  activation by the AT1 receptor leads to an increase in protein  synthesis via activation of a downstream kinase, Mnk1  (32).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_77|19171933|18039|RESULTS|0:0|This  mutant form of AngII was previously shown not to activate G proteins  (21,  30).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_110|19171933|25257|RESULTS|0:0|RSK- and AKT-mediated Phosphorylations of BAD Are Essential for  AngII-stimulated Cell Protection:Our data suggest that RSK- and/or  AKT-mediated phosphorylation of BAD might be a molecular mechanism that is  responsible for the beta-arrestin-2-mediated anti-apoptotic effects of AngII  on VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_129|19171933|28193|RESULTS|0:0|The level of SII-induced p90RSK and BAD phosphorylation were  determined as described above and expressed folds over basal phosphorylation  in non-stimulated (NS) cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_138|19171933|29883|RESULTS|0:0|However, such experiments are  only relevant to the situation in VSMCs if the signaling pathway we have  identified in the VSMCs also operates in the HEK-293 cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_149|19171933|32755|RESULTS|0:0|As shown in Fig. 4,  F and G, this stimulation leads to prolonged  increases in both p90RSK and BAD phosphorylation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_192|19171933|40327|DISCUSSION|0:0|Although there has been a  report showing beta-arrestin-1-dependent AKT activation in response to  thrombin mediated through 7TM protease-activated receptors  (27), its function in  apoptosis was not studied.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_199|19171933|41648|DISCUSSION|0:0|Levels of p90RSK (C) and BAD (D) phosphorylation in each  sample were determined as described for  Fig. 2 and expressed as percent  of the maximal phosphorylation in control (CTL) siRNA-transfected  cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_210|19171933|43088|DISCUSSION|0:0|Nonetheless, our data  show that inhibition of either ERK or RSK, but not PI3K activities completely  abolishes phosphorylation of BAD at this site following activation of the  AT1 receptor (Figs. 3B and  4E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_12|19171933|1260|abstract|0:0|For example, it has been shown that stimulation of a number of 7TMRs including  the N-formyl peptide receptor induces apoptosis in beta-arrestin  1/2 double knock-out mouse embryonic fibroblasts, and that reintroduction of  either beta-arrestin-1 or -2 completely prevents this apoptosis  (5).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_76|19171933|18039|RESULTS|0:0|To establish whether the beta-arrestin-2-dependent  AT1R-mediated inhibition of apoptotic processes can be accomplished  in the absence of G protein activation, we stimulated VSMCs with an AngII  analog, [Sar1,Ile4,Ile8]AngII (SII).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_100|19171933|20791|RESULTS|0:0|The reduction is observed only after a  2-min stimulation, suggesting that, as previously shown in HEK-293 cells  (22), prior to that time  activation proceeds exclusively through G protein-dependent mechanisms.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_121|19171933|28193|RESULTS|0:0|Effects of silencing beta-arrestin-2 expression on ERK-RSK-BAD  phosphorylation as well as AKT activation in response to AngII in rat  VSMCs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_122|19171933|28193|RESULTS|0:0|A-G, indicated siRNA-transfected VSMCs were serum-starved  for ~24 h and then stimulated with 100 nm AngII at 37  C  for the indicated periods.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_145|19171933|31858|RESULTS|0:0|After  beta-arrestin-2 siRNA transfection, there is almost complete loss of the  AngII-stimulated BAD phosphorylation at Ser75, the homologous site  of Ser113 in human BAD (Fig. 4,  D and E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_161|19171933|36633|DISCUSSION|0:0|In the case of AT1AR-mediated ERK activation, it has been  demonstrated that upon activation of the receptor, beta-arrestin-2 scaffolds  the components of the ERK cascade, Raf-1, MEK1, and ERK1/2, into the receptor  complex, leading to activation of ERK1/2  (2,  43).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_166|19171933|36633|DISCUSSION|0:0|However, very little is  known about how phosphorylation of cytoplasmic ERK substrates, downstream of  beta-arrestin signaling, regulates cellular responses.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_194|19171933|40327|DISCUSSION|0:0|Our results also demonstrate that the  activity of PI3K, the upstream kinase of AKT, is required for AngII-stimulated  protection from apoptotic challenges in VSMCs  (Fig. 3, C and  D).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_206|19171933|43088|DISCUSSION|0:0|We show that p90RSK is a kinase that transfers the beta-arrestin-mediated  ERK activation signal to anti-apoptotic effects in response to AT1  receptor activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_207|19171933|43088|DISCUSSION|0:0|RSK is a well known ERK substrate and mediates signals to  many cellular responses, including cell survival, through phosphorylation of  its downstream targets (40,  41).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_231|19171933|48008|DISCUSSION|0:0|Our data establish a  mechanism by which AngII leads to cellular protection as well as demonstrate  that beta-arrestin-2 is a key mediator of this mechanism.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_14|19171933|1260|abstract|0:0|beta-Arrestin-2, particularly a dephosphorylated form, has been shown to  facilitate inhibition of NF-kappaB activation in response to UV, leading to  promotion of UV-induced cell death  (8).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_27|19171933|3755|abstract|0:0|In the case of AKT activation,  stimulation of 7TM protease-activated receptors with thrombin has been shown  to activate AKT in a beta-arrestin-1-dependent manner  (27).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_114|19171933|25257|RESULTS|0:0|These results strongly support the thesis that  beta-arrestin-2 mediates AngII-stimulated cell protection by regulating RSK-  and AKT-mediated phosphorylation of BAD.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_125|19171933|28193|RESULTS|0:0|Values were expressed as percent of the maximal phosphorylation  of ERK1/2 obtained in control (CTL) siRNA-transfected cells.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_128|19171933|28193|RESULTS|0:0|H and  I, serum-starved VSMCs were stimulated with 10 mum SII  for 5 min.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.62	19171933_139|19171933|29883|RESULTS|0:0|As shown in  Fig. 4, A-C,  in HEK-293 cells stably transfected with a plasmid expressing the  AT1A receptor, AngII provokes a protracted activation (assessed by  phosphorylation of Thr359/Ser363) of p90RSK.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_3|19171933|96|abstract|0:0|Here we demonstrate that  beta-arrestin-2 mediates anti-apoptotic cytoprotective signaling stimulated  by a typical 7-transmembrane receptor the angiotensin ATII 1A receptor,  expressed endogenously in rat vascular smooth muscle cells or by transfection  in HEK-293 cells.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_78|19171933|18039|RESULTS|0:0|As shown in  Fig. 1, H and  I, stimulation of the cells with SII leads to significant  decreases (35-45%) in the levels of cleaved caspase-3 upon hydrogen peroxide  or etoposide treatment.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_163|19171933|36633|DISCUSSION|0:0|In particular, ERK  activated via the beta-arrestin-2-dependent pathway is confined to the  cytoplasm, whereas ERK activated via G proteins translocates into the nucleus  (22,  26).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_203|19171933|41648|DISCUSSION|0:0|Levels of phosphorylation in each time point were expressed as percent of the  maximal phosphorylation obtained in three independent experiments  (G).|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19171933_1|19171933|27312|#section_info|0:0|decreases in these levels in cells  overexpressing the wild-type BAD, |#main_body|GO:0043065|positive regulation of apoptotic process|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
##EndOfRet##
19171933_10|19171933|33204|#section_info|0:0|Our results demonstrate  that BAD phosphorylation by RSK is mediated predominantly by  beta-arrestin-2-dependent signaling (Figs.  2G and  4E) and also suggest  that its phosphorylation by AKT is partially dependent on|#main_body|GO:0051897|positive regulation of protein kinase B signaling cascade|#go_definition|IMP|GOA|Arrb1(25387)|#gene_synonym
0.74	19171933_144|19171933|31858|RESULTS|0:0|Despite this evidence that beta-arrestin-2-mediated ERK activation  accounts for only the later (>5 min) occurring phosphorylation of p90RSK,  the data in Fig. 4, D and  E, suggest that, as in the VSMCs, almost all of the  downstream phosphorylation of BAD by RSK is mediated by the pool of p90RSK,  which is activated through beta-arrestin-dependent ERK.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.69	19171933_110|19171933|25257|RESULTS|0:0|RSK- and AKT-mediated Phosphorylations of BAD Are Essential for  AngII-stimulated Cell Protection:Our data suggest that RSK- and/or  AKT-mediated phosphorylation of BAD might be a molecular mechanism that is  responsible for the beta-arrestin-2-mediated anti-apoptotic effects of AngII  on VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19171933_113|19171933|25257|RESULTS|0:0|Fig. 3B shows that  LY294002 blocks AngII-induced activation of AKT as assessed by phosphorylation  of AKT Ser473, and SL0101 blocks phosphorylation of BAD at the RSK  site, BAD Ser113.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19171933_114|19171933|25257|RESULTS|0:0|These results strongly support the thesis that  beta-arrestin-2 mediates AngII-stimulated cell protection by regulating RSK-  and AKT-mediated phosphorylation of BAD.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19171933_168|19171933|36633|DISCUSSION|0:0|The present study  reveals anti-apoptosis mediated by BAD phosphorylation as another downstream  response of beta-arrestin-mediated ERK signaling stimulated by a 7TMR.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.68	19171933_210|19171933|43088|DISCUSSION|0:0|Nonetheless, our data  show that inhibition of either ERK or RSK, but not PI3K activities completely  abolishes phosphorylation of BAD at this site following activation of the  AT1 receptor (Figs. 3B and  4E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.67	19171933_211|19171933|43088|DISCUSSION|0:0|Such data clearly  demonstrate that BAD phosphorylation at Ser113 in response to  AT1 receptor activation is mediated through the ERK-RSK pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19171933_134|19171933|29883|RESULTS|0:0|The AT1AR-stimulated ERK-RSK-BAD Phosphorylation Cascade in  HEK-293 Cells Is Also Mediated by  beta-Arrestin-2:Phosphorylation of BAD is thought to control  its apoptotic activity by regulating its functionally antagonistic binding to  anti-apoptotic proteins such as Bcl-xL (dephosphorylated form)  (11,  20) or the scaffold protein  14-3-3 (phosphorylated form)  (19).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.66	19171933_142|19171933|29883|RESULTS|0:0|Confirming that virtually all of the AngII-induced  phosphorylation of p90RSK at Thr359 and Ser363 is  mediated by ERK, the MEK inhibitor U0126 completely abolishes the p90RSK  phosphorylation response (Fig. 4C).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_146|19171933|31858|RESULTS|0:0|As expected, virtually all the BAD  phosphorylation at this site is also blocked by the selective RSK inhibitor  SL0101 and MEK inhibitor U0126 (Fig. 4E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_207|19171933|43088|DISCUSSION|0:0|RSK is a well known ERK substrate and mediates signals to  many cellular responses, including cell survival, through phosphorylation of  its downstream targets (40,  41).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.64	19171933_209|19171933|43088|DISCUSSION|0:0|In addition to RSK, PKA and AKT have been considered as putative upstream  kinases for BAD phosphorylation  (16,  17,  44).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_103|19171933|20791|RESULTS|0:0|Moreover, our recent high  throughput proteomics screening using the stable isotope labeling amino acid  in cell culture method have revealed that the level of p90RSK phosphorylation  is increased by SII stimulation in HEK-293 cells expressing the  AT1A  receptor.3  Accordingly, we next tested whether phosphorylation of p90RSK occurs upon  stimulation with AngII and whether this is mediated by beta-arrestin-2.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_108|19171933|24202|RESULTS|0:0|As  shown in Fig. 2, H and  I, SII stimulates both p90RSK and phosphorylation of BAD  at the RSK site, thus confirming the G protein independence of these  responses.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_116|19171933|26491|RESULTS|0:0|To directly test whether RSK- and AKT-mediated phosphorylation of BAD are  required for the anti-apoptotic actions of AngII, we studied the nature of  overexpressed wild-type and phosphorylation-deficient mutants of BAD in VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_170|19171933|38423|DISCUSSION|0:0|Kinase activities of both RSK and AKT as well as BAD phosphorylation are  required for AngII-promoted cellular protection in rat VSMCs.|#fig_caption|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_101|19171933|20791|RESULTS|0:0|Ribosomal S6 kinase (RSK) is a well known downstream kinase for ERK signaling  and it mediates a variety of physiological responses including anti-apoptosis  (40,  41).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_102|19171933|20791|RESULTS|0:0|Furthermore, RSK is  activated by phosphorylation in the cytoplasm  (40,  41) where ERK activated by  beta-arrestin-dependent mechanisms is confined  (22,  26).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_166|19171933|36633|DISCUSSION|0:0|However, very little is  known about how phosphorylation of cytoplasmic ERK substrates, downstream of  beta-arrestin signaling, regulates cellular responses.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_167|19171933|36633|DISCUSSION|0:0|The only known  example is the very recent finding that beta-arrestin-2-mediated ERK  activation by the AT1 receptor leads to an increase in protein  synthesis via activation of a downstream kinase, Mnk1  (32).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.61	19171933_206|19171933|43088|DISCUSSION|0:0|We show that p90RSK is a kinase that transfers the beta-arrestin-mediated  ERK activation signal to anti-apoptotic effects in response to AT1  receptor activation.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
19171933_11|19171933|44370|#section_info|0:0|Our data show that knocking-down beta-arrestin-2 expression leads to  almost complete inhibition in RSK-mediated phosphorylation of BAD following|#main_body|GO:0001934|positive regulation of protein phosphorylation|#go_definition|IMP|GOA|Arrb2(25388)|#gene_synonym
0.66	19171933_210|19171933|43088|DISCUSSION|0:0|Nonetheless, our data  show that inhibition of either ERK or RSK, but not PI3K activities completely  abolishes phosphorylation of BAD at this site following activation of the  AT1 receptor (Figs. 3B and  4E).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_110|19171933|25257|RESULTS|0:0|RSK- and AKT-mediated Phosphorylations of BAD Are Essential for  AngII-stimulated Cell Protection:Our data suggest that RSK- and/or  AKT-mediated phosphorylation of BAD might be a molecular mechanism that is  responsible for the beta-arrestin-2-mediated anti-apoptotic effects of AngII  on VSMCs.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_134|19171933|29883|RESULTS|0:0|The AT1AR-stimulated ERK-RSK-BAD Phosphorylation Cascade in  HEK-293 Cells Is Also Mediated by  beta-Arrestin-2:Phosphorylation of BAD is thought to control  its apoptotic activity by regulating its functionally antagonistic binding to  anti-apoptotic proteins such as Bcl-xL (dephosphorylated form)  (11,  20) or the scaffold protein  14-3-3 (phosphorylated form)  (19).|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
0.63	19171933_211|19171933|43088|DISCUSSION|0:0|Such data clearly  demonstrate that BAD phosphorylation at Ser113 in response to  AT1 receptor activation is mediated through the ERK-RSK pathway.|#main_body|#go_id|#go_term|#go_definition|#evidence_code|#evidence_type|#gene_name|#gene_synonym
##EndOfRet##
